Mission statement

ALHI will bring together Australia’s leading researchers in respiratory health, along with cutting-edge engineering, data science and manufacturing, to help unlock the full disruptive potential of the revolutionary XV Technology™.  We are extremely excited about the opportunity to redefine how lung diseases are diagnosed and treated all over the world. The resulting successful commercialisation of two generations of scanners will be a major breakthrough in pulmonary health care, establishing Australia as a world leader in lung healthcare technology.

Success in this project will make a very big difference to the lives of children and adults suffering from lung disease in Australia and around the world.
Mark Brooke
Chief Executive Officer
Lung Foundation Australia

Latest from Twitter

Last night ALHI attended the launch of the Global Health Alliance https://t.co/vnGnKl66CJ, opened by Patron @JBrumby and speakers including Terry Symonds from DHS. Glham is a collaboration based ecosystem working to support WHO global health challenges in our region.


COPD is the 3rd leading cause of death globally and 5th in Australia. Prevalence has increased 44% over the last 25 years. Under diagnosed - our lungs compensate until disease is advanced, we need to raise awareness and develop effective early screening to help prevent disease.

Just 2 days until #WorldCOPDDay

Why is it important?

- There are 300 million current cases of #COPD in the world.
- COPD is currently the third leading cause of death globally.
- It is highly prevalent in low resource countries.

Find out more here https://t.co/5Qg9tFiowD.

Load More...